Loading...
Loading...
Indian Pharmaceutical Exporter Β· #3 for Metronidazole Β· $7.9M export value Β· DGFT Verified
Otsuka Pharmaceutical India Private Limited is the #3 Indian exporter of Metronidazole with $7.9M in export value and 490 verified shipments. Otsuka Pharmaceutical India Private Limited holds a 3.9% market share in Metronidazole exports across 52 countries. The company exports 2 pharmaceutical products worth $21.9M across 2 therapeutic categories.

| Country | Value | Shipments | Share |
|---|---|---|---|
| GEORGIA | $1.3M | 75 | 19.7% |
| CHINA | $863.3K | 80 | 13.1% |
| MYANMAR | $573.8K | 36 | 8.7% |
| KENYA | $355.8K | 24 | 5.4% |
| MOROCCO | $311.2K | 22 | 4.7% |
| PERU | $302.3K | 19 | 4.6% |
| COLOMBIA | $261.8K | 18 | 4.0% |
| YEMEN | $242.9K | 11 | 3.7% |
| TANZANIA | $197.0K | 15 | 3.0% |
| MADAGASCAR | $163.5K | 13 | 2.5% |
Otsuka Pharmaceutical India Private Limited exports Metronidazole to 53 countries. The largest destination is GEORGIA accounting for 19.7% of Otsuka Pharmaceutical India Private Limited's Metronidazole shipments, followed by CHINA (13.1%) and MYANMAR (8.7%). These destinations reflect Otsuka Pharmaceutical India Private Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| LLC SERENE PHARMA | PAKISTAN | $649.2K | 38 |
| TOO AVITSENA LTD | GEORGIA | $562.3K | 41 |
| BIO SYSTEM (BIO SYS) | MYANMAR | $480.7K | 32 |
| TOO AVITSENA LIMITED | KAZAKISTAN | $357.4K | 19 |
| SUNMED LTD. | KYRGHYSTAN | $276.0K | 23 |
| LLC SERENE PHARMA HOUSE NO 9 STREET MUHTAR ASHRAFI YASHNAB AD | GEORGIA | $185.6K | 8 |
India exported $68.7M worth of Metronidazole through 13,685 shipments from 962 suppliers to 182 countries, serving 2,820 buyers globally. Otsuka Pharmaceutical India Private Limited contributes $7.9M to this total, accounting for 3.9% of India's Metronidazole exports. Otsuka Pharmaceutical India Private Limited ships Metronidazole to 53 countries through 93 buyers.
Otsuka Pharmaceutical India Private Limited's average Metronidazole shipment value is $16.1K per consignment, based on 490 shipments totaling $7.9M. The largest destination is GEORGIA (19.7% of Otsuka Pharmaceutical India Private Limited's Metronidazole exports).
Otsuka Pharmaceutical India Private Limited ranks #3 among 962 Indian Metronidazole exporters with a 3.9% market share. The top 3 exporters are UNICHEM LABORATORIES LIMITED ($11.7M), OTSUKA PHARMACEUTICAL INDIA PRIVATE LIMITED ($7.9M), J B CHEMICALS AND PHARMACEUTICALS LIMITED ($7.3M). Otsuka Pharmaceutical India Private Limited processed 490 shipments to 52 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| METRONIDAZOLE INJECTION USP (0.5% W/V) 1 | $1.4M | 74 |
| METRONIDAZOLE INJECTION USP (0.5% W/V) 100ML PLASTIC BOTTLE (METRID) | $682.5K | 56 |
| METRONIDAZOLE INJECTION USP (0.5% W/V) 100ML PLASTIC BOTTLE (METRID)NOS | $357.4K | 45 |
| METRONIDAZOLE INJECTION USP 0.5% W/V 100ML PLASTIC BOTTLE METRID | $347.0K | 15 |
| METRONIDAZOLE INJECTION USP 0 5 W V 100ML PLASTIC BOTTLE METRID | $255.2K | 13 |
| METRONIDAZOLE INJECTION USP (0.5% W/V) 100ML PLASTIC BOTTLE (METRIS) (MEDICAL PRODUCTS) | $241.9K | 16 |
| METRONIDAZOLE INJECTION USP (0.5% W/V) 100 ML PLASTIC BOTTLE (METRIS) | $219.6K | 16 |
| METRONIDAZOLE INJECTION 0.5% W/V 100 MLUSP PLASTIC BOTTLE (METRIS) | $196.0K |
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | UNICHEM LABORATORIES LIMITED | $11.7M | 233 | 2 | $50.0K |
| 3 | OTSUKA PHARMACEUTICAL INDIA PRIVATE LIMITED β | $7.9M | 490 | 52 | $16.1K |
| 4 | J B CHEMICALS AND PHARMACEUTICALS LIMITED | $7.3M | 517 | 17 | $14.2K |
| 1 | MEDOPHARM | $7.0M |
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 1,795 | 13.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,190 | 8.7% |
| SAHAR AIR | 1,058 | 7.7% |
| JNPT/ NHAVA SHEVA SEA | 952 | 7.0% |
| JNPT | 661 | 4.8% |
| DELHI AIR CARGO ACC (INDEL4) | 626 | 4.6% |
| AHEMDABAD ICD | 520 | 3.8% |
| DELHI AIR | 443 | 3.2% |
OPI's export operations are currently navigating a complex geopolitical landscape. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended delivery timelines. These challenges are particularly acute for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management. (pharmaceuticalcommerce.com)
In the United States, recent tariff escalations have introduced additional hurdles for Indian pharmaceutical exporters. The imposition of tariffs on imports from countries including India has raised concerns about the competitiveness of Indian generics in the U.S. market, potentially impacting OPI's export volumes and profit margins. (apnews.com)
Conversely, the European Union's stringent regulatory frameworks, such as the Falsified Medicines Directive, present both challenges and opportunities. Compliance with these regulations demands significant investment in quality assurance but also enhances the credibility of compliant exporters like OPI, potentially facilitating smoother market access and bolstering the company's reputation in the EU.
The global pharmaceutical industry is witnessing heightened scrutiny regarding quality and compliance. The U.S. FDA has intensified inspections of Indian manufacturing facilities, underscoring the necessity for stringent adherence to Good Manufacturing Practices (GMP). OPI's commitment to quality is evident through its accreditations, including WHO-GMP and PIC/S certifications, which are critical for maintaining export eligibility and market trust. (otsukapharma.in)
Additionally, the prevalence of counterfeit drugs has prompted international bodies to enforce stricter regulations. For OPI, this environment necessitates continuous investment in quality control systems and compliance infrastructure to meet evolving standards and safeguard its market position.
Otsuka Pharmaceutical India Private Limited exports 2 products worth $21.9M. Beyond Metronidazole, top products include Amino. View the complete Otsuka Pharmaceutical India Private Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Metronidazole β including regulatory updates, trade policy changes, and competitive landscape analysis β will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records β the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Otsuka Pharmaceutical India Private Limited's Metronidazole exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Otsuka Pharmaceutical India Private Limited
Full Company Profile β
2 products Β· $21.9M total trade Β· 2 categories
| AMANYS PHARMA | MOROCCO | $185.3K | 12 |
| HANAI S.R.L. | PERU | $158.1K | 11 |
| OFFICE PHARMACEUTIQUE MALGACHE S.A. | MADAGASCAR | $142.1K | 10 |
| FARMALOGICA S A Y O LAAX ZONA FRAN | COLOMBIA | $132.6K | 8 |
Otsuka Pharmaceutical India Private Limited supplies Metronidazole to 93 buyers globally. The largest buyer is LLC SERENE PHARMA (PAKISTAN), followed by TOO AVITSENA LTD (GEORGIA) and BIO SYSTEM (BIO SYS) (MYANMAR). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
| 15 |
| METRONIDAZOLE INTRAVENOUS INFUSION BP (0 | $150.4K | 7 |
| METRONIDAZOLE INJECTION USP (0.5% W/V) 100 ML PLASTIC BOTTLE (TENAFLOX) | $149.5K | 10 |
Otsuka Pharmaceutical India Private Limited exports 101 distinct Metronidazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is METRONIDAZOLE INJECTION USP (0.5% W/V) 1 with 74 shipments worth $1.4M.
| 141 |
| 25 |
| $50.0K |
Otsuka Pharmaceutical India Private Limited ranks #3 among 962 Indian Metronidazole exporters. Average shipment value of $16.1K compared to the market average of $71.4K. The closest competitors by value are UNICHEM LABORATORIES LIMITED and J B CHEMICALS AND PHARMACEUTICALS LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 182+ countries, 2,820+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Otsuka Pharmaceutical India Private Limited.
Request DemoView Pricing βTrade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Metronidazole. For current shipment-level data, contact TransData Nexus.